ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ACE et diagnostic précoce de récidive dans les différents sous-types moléculaires de cancer du sein : comparaison au CA 15-3

Published:2016-05 Issue:5 Volume:103 Page:434-443
ISSN:0007-4551
Container-title:Bulletin du Cancer
language:fr
Short-container-title:Bulletin du Cancer

Author:

Riedinger Jean-Marc,Goussot Vincent^ORCID,Desmoulins Isabelle,Lorgis Véronique,Coutant Charles,Beltjens Françoise,Lizard Sarab,Fumoleau Pierre

Publisher

Elsevier BV

Reference77 articles.

1. Breast cancer follow-up and management after primary treatment: American society of clinical oncology clinical practice guideline update;Khatcheressian;J Clin Oncol,2013

2. Clinical practice. Follow-up of patients with early breast cancer;Hayes;N Engl J Med,2007

3. American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer;Harris;J Clin Oncol,2007

4. National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers;Sturgeon;Clin Chem,2008

5. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer;Goldhirsch;J Clin Oncol,2003

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review;Exploration of Targeted Anti-tumor Therapy;2025-05-15

2. Searching for the “Holy Grail” of breast cancer recurrence risk: a narrative review of the hunt for a better biomarker and the promise of circulating tumor DNA (ctDNA);Breast Cancer Research and Treatment;2024-02-15

3. Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates;SAGE Open Medicine;2022-01

4. Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study;Breast Cancer;2020-02-10

5. Clinical value of CEA for detection of distant metastases in newly diagnosed breast cancer: comparison with CA 15-3;Annales de biologie clinique;2017-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.7亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2025 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3